| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
PDE1-IN-2 manufacturers
- PDE1-IN-2
-
- $347.00
-
2026-04-20
- CAS:1904611-63-7
- Purity:
- Supply Ability: 10g
|
| | PDE1-IN-2 Basic information |
| Product Name: | PDE1-IN-2 | | Synonyms: | PDE1-IN-2;PDE1 inhibitor 2;PDE1IN2,PDE1 IN 2,PDE-1-IN-2;1,2,4-Triazolo[4,3-a]pyrazin-8(7H)-one, 6-bromo-7-(cyclopentylmethyl)-3-(tetrahydro-2H-pyran-4-yl)- | | CAS: | 1904611-63-7 | | MF: | C16H21BrN4O2 | | MW: | 381.27 | | EINECS: | | | Product Categories: | | | Mol File: | 1904611-63-7.mol |  |
| | PDE1-IN-2 Chemical Properties |
| Boiling point | 563.8±60.0 °C(Predicted) | | density | 1.70±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 25 mg/mL (65.57 mM) | | pka | -0.33±0.40(Predicted) | | form | Solid | | color | White to gray |
| | PDE1-IN-2 Usage And Synthesis |
| Description | PDE1-IN-2 is an inhibitor of PDE1 extracted from patent WO2016/55618 A1, example 31; has IC50 values of 6, 140 and 164 nM for PDE1C, PDE1B and PDE1A, respectvely. | | Uses | PDE1-IN-2 is a PDE1 inhibitor extracted from patent WO2016/55618 A1, example 31. PDE1-IN-2 has IC50 values of 6 nM, 140 nM and 164 nM for PDE1C, PDE1B and PDE1A, respectvely. PDE1-IN-2 is developed for the research of neurodegenerative disorders and psychiatric disorders[1]. | | IC 50 | PDE1A: 164 nM (IC50); PDE1B: 140 nM (IC50); PDE1C: 6 nM (IC50) | | References | [1]. WO2016055618A1 |
| | PDE1-IN-2 Preparation Products And Raw materials |
|